CN100522264C - Preparation method of double-layer tissue engineering skin comprising basement membrane structure - Google Patents
Preparation method of double-layer tissue engineering skin comprising basement membrane structure Download PDFInfo
- Publication number
- CN100522264C CN100522264C CNB2006100951229A CN200610095122A CN100522264C CN 100522264 C CN100522264 C CN 100522264C CN B2006100951229 A CNB2006100951229 A CN B2006100951229A CN 200610095122 A CN200610095122 A CN 200610095122A CN 100522264 C CN100522264 C CN 100522264C
- Authority
- CN
- China
- Prior art keywords
- engineering skin
- skin
- basement membrane
- preparation
- tissue engineering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002469 basement membrane Anatomy 0.000 title claims description 37
- 238000002360 preparation method Methods 0.000 title claims description 21
- 210000001519 tissue Anatomy 0.000 title claims description 20
- 238000000034 method Methods 0.000 claims abstract description 15
- 230000008569 process Effects 0.000 claims abstract description 3
- 210000003491 skin Anatomy 0.000 claims description 51
- 230000008520 organization Effects 0.000 claims description 23
- 229920002101 Chitin Polymers 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 8
- 230000003203 everyday effect Effects 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 4
- 102000016942 Elastin Human genes 0.000 claims description 4
- 108010014258 Elastin Proteins 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 229920002549 elastin Polymers 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- 210000002510 keratinocyte Anatomy 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 3
- 229910001424 calcium ion Inorganic materials 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 210000002950 fibroblast Anatomy 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 239000007788 liquid Substances 0.000 abstract description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 210000000721 basilar membrane Anatomy 0.000 abstract 2
- 238000009395 breeding Methods 0.000 abstract 1
- 230000001488 breeding effect Effects 0.000 abstract 1
- 239000002355 dual-layer Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 210000002615 epidermis Anatomy 0.000 description 16
- 150000001875 compounds Chemical class 0.000 description 10
- 238000004043 dyeing Methods 0.000 description 9
- 238000011532 immunohistochemical staining Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000002734 Collagen Type VI Human genes 0.000 description 4
- 108010043741 Collagen Type VI Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000301 hemidesmosome Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 101100380342 Catharanthus roseus ASO gene Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 102000008730 Nestin Human genes 0.000 description 1
- 108010088225 Nestin Proteins 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 description 1
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000005055 nestin Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100951229A CN100522264C (en) | 2006-09-14 | 2006-09-14 | Preparation method of double-layer tissue engineering skin comprising basement membrane structure |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100951229A CN100522264C (en) | 2006-09-14 | 2006-09-14 | Preparation method of double-layer tissue engineering skin comprising basement membrane structure |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1923301A CN1923301A (en) | 2007-03-07 |
CN100522264C true CN100522264C (en) | 2009-08-05 |
Family
ID=37816242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100951229A Active CN100522264C (en) | 2006-09-14 | 2006-09-14 | Preparation method of double-layer tissue engineering skin comprising basement membrane structure |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100522264C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773688B (en) * | 2010-02-05 | 2013-10-23 | 中国人民解放军第四军医大学 | Preparation method of tissue engineering skin containing appendant organs |
CN101879329A (en) * | 2010-06-21 | 2010-11-10 | 蒋明军 | Artificial skin containing basilar membrane and construction method thereof |
CN101955908B (en) * | 2010-07-22 | 2013-01-23 | 中国医学科学院皮肤病研究所 | Artificial epidermis in-vitro model for detecting sensitization of material and screening medicament |
FR2976001B1 (en) * | 2011-05-30 | 2014-10-31 | Oreal | RECONSTRUCTED SCALP LEATHER MODEL AND METHOD FOR SCREENING ACTIVE MOLECULES |
CN109550080A (en) * | 2019-01-24 | 2019-04-02 | 中国人民解放军陆军特色医学中心 | A kind of artificial bilayer's skin and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1310027A (en) * | 2001-02-06 | 2001-08-29 | 中国人民解放军第三军医大学第三附属医院 | Preparation of compound artificial skin |
CN1468634A (en) * | 2002-07-15 | 2004-01-21 | 上海组织工程研究与开发中心 | Double-layered artificial skin and its prepn process |
CN1607012A (en) * | 2003-10-13 | 2005-04-20 | 刘凯 | Method for preparing human body tissue engineering skin |
-
2006
- 2006-09-14 CN CNB2006100951229A patent/CN100522264C/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1310027A (en) * | 2001-02-06 | 2001-08-29 | 中国人民解放军第三军医大学第三附属医院 | Preparation of compound artificial skin |
CN1468634A (en) * | 2002-07-15 | 2004-01-21 | 上海组织工程研究与开发中心 | Double-layered artificial skin and its prepn process |
CN1607012A (en) * | 2003-10-13 | 2005-04-20 | 刘凯 | Method for preparing human body tissue engineering skin |
Also Published As
Publication number | Publication date |
---|---|
CN1923301A (en) | 2007-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101352586B (en) | Method for preparing full-thickness skin for toxicity test by stem cell raft type cultivation | |
Braziulis et al. | Modified plastic compression of collagen hydrogels provides an ideal matrix for clinically applicable skin substitutes | |
CN102051343A (en) | Bioengineered tissue constructs and methods for producing and using them | |
CN104726396A (en) | Method for building full-thickness skin models | |
CN105734009B (en) | In-vitro recombinant human skin epidermis model and preparation method and application thereof | |
CN100522264C (en) | Preparation method of double-layer tissue engineering skin comprising basement membrane structure | |
CN101302486B (en) | Acetobacter xylinum and method for preparing nano-cellulose skin tissue repair material by using the same | |
EP3167913B1 (en) | A method for preparing a three-dimensionally cultured skin comprising dermis and epidermis, and the cultured skin made therefrom | |
CN105079783B (en) | Pharmaceutical composition and its preparation method and application | |
CN101318030A (en) | Method for preparing organ type artificial skin for toxicity inspection by employing built-in cultivation method | |
CN106620855B (en) | A kind of construction method of composite tissue engineering skin | |
JP2017525438A (en) | Tissue graft | |
JPWO2005014774A1 (en) | Animal cell culture carrier, animal cell culture method and transplantation method using the culture carrier | |
CN1257262C (en) | Pouring type biologic reactor system in vitro constructure of dual active skin | |
CN101045916A (en) | Follicular stem cell originated from human hair and its amplifying prepn process | |
CN114045257A (en) | Vascularized osteoblast membrane scaffold complex and preparation thereof | |
CN101138653A (en) | Organization engineering skin containing adipose layer and method of preparing the same | |
EP2029186A1 (en) | Isolated nature-identical collagen | |
EP3967748A1 (en) | Nanocellulose 3d matrix for cultivating human and animal cells in vitro | |
CN109722410B (en) | 3D full-layer skin model, culture medium for forming same and preparation method | |
CN109112101A (en) | A kind of fibroblast culture medium and its application | |
CN107312744A (en) | A kind of Buccal mucosa cell nutrient solution containing serum | |
Fusenig et al. | Keratinization and structural organization in epidermal cell cultures | |
JP5293499B2 (en) | Collagen vitrigel with suppressed calcium phosphate deposition | |
CN1415384A (en) | Method for preparing all layers of skin used by tissue engineering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WEILIBAO BIO-TECHNOLOGY (CHENGDU) CO., LTD. Free format text: FORMER OWNER: NO.3 HOSPITAL ATTACHED TO NO.3 MILITARY MEDICAL UNIV., P.L.A.;NO.3 HOSPITAL ATTACHED TO NO.3 MILITAR Effective date: 20150121 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 400042 TO: 611731 |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150121 Address after: 611731, No. 9 South Road, Chengdu high tech Zone, Sichuan, China Patentee after: Weili biological technology (Chengdu) Co., Ltd. Address before: Chongqing city Yuzhong District Daping 400042 Yangtze River Branch No. 10 Patentee before: The Third Affiliated Hospital of Third Military Medical University of PLA |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151208 Address after: Jiulongpo Branch Park four street 400041 Chongqing City No. 70-1, No. 70-2 Patentee after: Chongqing Weili Biological Technology Co., Ltd. Address before: 611731, No. 9 South Road, Chengdu high tech Zone, Sichuan, China Patentee before: Weili biological technology (Chengdu) Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190516 Address after: 610015 No. 9 Herui South Road, West Park of Chengdu High-tech Zone, Sichuan Province Patentee after: Weili biological technology (Chengdu) Co., Ltd. Address before: 400041 No. 70-1 and No. 70-2 Keyuan Fourth Street, Jiulongpo District, Chongqing Patentee before: Chongqing Weili Biological Technology Co., Ltd. |
|
TR01 | Transfer of patent right |